Hong‐Xing Wu

608 total citations
19 papers, 423 citations indexed

About

Hong‐Xing Wu is a scholar working on Clinical Psychology, Epidemiology and Hepatology. According to data from OpenAlex, Hong‐Xing Wu has authored 19 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 5 papers in Epidemiology and 5 papers in Hepatology. Recurrent topics in Hong‐Xing Wu's work include Child and Adolescent Psychosocial and Emotional Development (5 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Hong‐Xing Wu is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (5 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). Hong‐Xing Wu collaborates with scholars based in Canada, China and United States. Hong‐Xing Wu's co-authors include Richard E. Tremblay, Raymond H. Baillargeon, Mark Zoccolillo, Daniel Pérusse, Michel Boivin, Kate Keenan, Sylvana M. Côté, Jeroen K. Vermunt, Elisa Romano and Jun Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Developmental Psychology.

In The Last Decade

Hong‐Xing Wu

18 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Xing Wu Canada 12 212 102 83 52 51 19 423
Seyed Amir Amin Yazdi Iran 9 228 1.1× 133 1.3× 38 0.5× 22 0.4× 25 0.5× 45 437
Mark Spellmann United States 10 253 1.2× 63 0.6× 195 2.3× 24 0.5× 51 1.0× 13 593
Seyed Kaveh Hojjat Iran 11 228 1.1× 71 0.7× 64 0.8× 35 0.7× 102 2.0× 37 404
J. Alan Simmons United States 9 206 1.0× 124 1.2× 63 0.8× 52 1.0× 19 0.4× 21 413
Ian K. Villalta United States 10 342 1.6× 69 0.7× 107 1.3× 66 1.3× 128 2.5× 11 575
Vahdet Görmez Türkiye 8 286 1.3× 52 0.5× 68 0.8× 10 0.2× 60 1.2× 39 423
Karen Goodall United Kingdom 11 279 1.3× 154 1.5× 31 0.4× 38 0.7× 59 1.2× 35 473
Concepción López Soler Spain 13 248 1.2× 72 0.7× 53 0.6× 16 0.3× 44 0.9× 51 406
Tiffany B. Brown United States 9 221 1.0× 84 0.8× 10 0.1× 89 1.7× 81 1.6× 18 416
Jeffrey P. Burk United States 9 263 1.2× 69 0.7× 49 0.6× 38 0.7× 49 1.0× 14 376

Countries citing papers authored by Hong‐Xing Wu

Since Specialization
Citations

This map shows the geographic impact of Hong‐Xing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Xing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Xing Wu more than expected).

Fields of papers citing papers by Hong‐Xing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Xing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Xing Wu. The network helps show where Hong‐Xing Wu may publish in the future.

Co-authorship network of co-authors of Hong‐Xing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Xing Wu. A scholar is included among the top collaborators of Hong‐Xing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Xing Wu. Hong‐Xing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jia, Caixia, Hong‐Xing Wu, Aiqing Yang, et al.. (2024). Mechanism Research of QingReJieDu Formula for Treating Hepatitis B Virus Based on Network Pharmacology. Phytomedicine. 135. 155915–155915. 2 indexed citations
2.
Liu, Yuntao, Hong‐Xing Wu, Xing Chen, et al.. (2022). A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options. Science China Life Sciences. 65(9). 1866–1880. 19 indexed citations
3.
Armali, Chantal, H. G. Downie, Brian Berry, et al.. (2020). Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017. Vox Sanguinis. 116(2). 225–233.
4.
Ni, Xiaotian, Changqing Sun, Yaping Tian, et al.. (2020). Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?. Science China Life Sciences. 63(11). 1766–1767. 3 indexed citations
5.
Gao, Feng, et al.. (2020). Efficacy and safety of endovascular coiling vs surgical clipping for patients with ruptured carotid-ophthalmic aneurysm. Medicine. 99(47). e23235–e23235. 1 indexed citations
6.
Liu, Wei, et al.. (2017). No significant difference between chiari malformation type 1.5 and type I. Clinical Neurology and Neurosurgery. 157. 34–39. 12 indexed citations
7.
8.
Xiao, Chao-Wu, Carla M. Wood, Eleonora Swist, et al.. (2016). Cardio-Metabolic Disease Risks and Their Associations with Circulating 25-Hydroxyvitamin D and Omega-3 Levels in South Asian and White Canadians. PLoS ONE. 11(1). e0147648–e0147648. 11 indexed citations
9.
Baillargeon, Raymond H., Claude L. Normand, Jean R. Séguin, et al.. (2007). The evolution of problem and social competence behaviors during toddlerhood: A prospective population‐based cohort survey. Infant Mental Health Journal. 28(1). 12–38. 41 indexed citations
10.
Wu, Hong‐Xing, et al.. (2007). Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999–2004. European Journal of Clinical Microbiology & Infectious Diseases. 26(3). 167–174. 21 indexed citations
11.
Baillargeon, Raymond H., Mark Zoccolillo, Kate Keenan, et al.. (2007). Gender differences in physical aggression: A prospective population-based survey of children before and after 2 years of age.. Developmental Psychology. 43(1). 13–26. 158 indexed citations
12.
Dawood, Magdy, et al.. (2006). Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada — a public health laboratory study. Canadian Journal of Microbiology. 52(10). 999–1005. 12 indexed citations
13.
Leung, Yvette, et al.. (2006). A Cross-Sectional Analysis of Acute Hepatitis B Virus Reported to the Vancouver Coastal Health Authority from 2000 to 2003. SHILAP Revista de lepidopterología. 20(7). 471–474. 3 indexed citations
14.
Wu, Hong‐Xing, Jun Wu, Tom Wong, et al.. (2006). Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004. Scandinavian Journal of Infectious Diseases. 38(6-7). 482–489. 20 indexed citations
15.
Baillargeon, Raymond H., et al.. (2006). Age differences in the prevalence of physical aggression among 5–11‐year‐old Canadian boys and girls. Aggressive Behavior. 33(1). 26–37. 59 indexed citations
16.
Romano, Elisa, Raymond H. Baillargeon, Isabel Fortier, et al.. (2005). Individual Change in Methylphenidate Use in a National Sample of Children Aged 2 to 11 Years. The Canadian Journal of Psychiatry. 50(3). 144–152. 6 indexed citations
17.
Baillargeon, Raymond H., et al.. (2004). Modeling intraindividual change over time in the absence of a “Gold Standard”. uO Research (University of Ottawa). 46(1). 7. 7 indexed citations
18.
Romano, Elisa, Raymond H. Baillargeon, Hong‐Xing Wu, et al.. (2004). A new look at inter-informant agreement on conduct disorder using a latent class approach. Psychiatry Research. 129(1). 75–89. 15 indexed citations
19.
Romano, Elisa, Raymond H. Baillargeon, Hong‐Xing Wu, Philippe Robaey, & Richard E. Tremblay. (2002). Prevalence of methylphenidate use and change over a two-year period: A nationwide study of 2- to 11-year-old Canadian children. The Journal of Pediatrics. 141(1). 71–75. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyed Amir Amin Yazdi Breakdown of academic impact, for papers by Mark Spellmann Breakdown of academic impact, for papers by Seyed Kaveh Hojjat Breakdown of academic impact, for papers by J. Alan Simmons Breakdown of academic impact, for papers by Ian K. Villalta Breakdown of academic impact, for papers by Vahdet Görmez Breakdown of academic impact, for papers by Karen Goodall Breakdown of academic impact, for papers by Concepción López Soler Breakdown of academic impact, for papers by Tiffany B. Brown Breakdown of academic impact, for papers by Jeffrey P. Burk
Rankless by CCL
2026